References
- Nasrallah HA . Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol. Psychiatry13(1) , 27–35 (2008).
- Theisen FM , GebhardtS, HaberhausenM et al. Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs. Psychiatr. Genet. 15(4) , 285–289 (2005).
- De Luca V , MuellerDJ, de Bartolomeis A, Kennedy JL. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int. J. Neuropsychopharmacol.10(5) , 697–704 (2007).
- Adkins DE , AbergK, McClayJL et al. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Mol. Psychiatry 16(3) , 321–332 (2011).
- Beckers S , ZegersD, de Freitas F, Mertens IL, van Gaal LF, van Hul W. Association study of MC4R with complex obesity and replication of the rs17782313 association signal. Mol. Genet. Metab.103(1) , 71–75 (2011).
- Yu Z , HanS, CaoX, ZhuC, WangX, GuoX. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring)20(2) , 396–406 (2012).
- Pagotto U , MarsicanoG, CotaD, LutzB, PasqualiR. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr. Rev.27(1) , 73–100 (2006).
- Sentissi O , EpelbaumJ, OlieJP, PoirierMF. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr. Bull.34(6) , 1189–1199 (2008).
- Malhotra AK , CorrellCU, ChowdhuryNI et al. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch. Gen. Psychiatry 69(9) , 904–912 (2012).
- Chowdhury NI , TiwariAK, SouzaRP et al. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene. Pharmacogenomics J. 13(3) , 272–279 (2013).
- Nurmi EL , SpilmanSL, WhelanF et al. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. Transl. Psychiatry 3 , e274 (2013).
- Park YM , ChoiJE, KangSG et al. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain. Hum. Psychopharmacol. 26(4–5) , 332–337 (2011).
- Tiwari AK , ZaiCC, LikhodiO et al. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in schizophrenia. Neuropsychopharmacology 35(6) , 1315–1324 (2010).
- Monteleone P , MilanoW, PetrellaC, CanestrelliB, MajM. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain. J. Clin. Psychopharmacol.30(4) , 441–445 (2010).
- Templeman LA , ReynoldsGP, ArranzB, SanL. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet. Genomics15(4) , 195–200 (2005).
- Ellingrod VL , BishopJR, MolineJ, LinYC, MillerDD. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacol. Bull.40(1) , 57–62 (2007).
- Kang SG , LeeHJ, ParkYM et al. Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Prog. Neuropsychopharmacol. Biol. Psychiatry 32(1) , 160–163 (2008).
- Yevtushenko OO , CooperSJ, O‘NeillR, DohertyJK, WoodsideJV, ReynoldsGP. Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. Br. J. Psychiatry192(6) , 424–428 (2008).
- Calarge CA , EllingrodVL, ZimmermanB, AcionL, SivitzWI, SchlechteJA. Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents. Psychiatr. Genet.19(6) , 320–327 (2009).
- Brandl EJ , FrydrychowiczC, TiwariAK et al. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog. Neuropsychopharmacol. Biol. Psychiatry 38(2) , 134–141 (2012).
- Fernandez E , CarrizoE, FernandezV et al. Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin. Schizophr. Res. 121(1–3) , 213–217 (2010).
- Kuo PH , KaoCF, ChenPY et al. Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients. J. Clin. Psychopharmacol. 31(6) , 705–711 (2011).
- Zhang XY , TanYL, ZhouDF et al. Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. J. Clin. Psychopharmacol. 27(3) , 246–251 (2007).
- Gregoor JG , van der Weide J, Loovers HM, van Megen HJ, Egberts TC, Heerdink ER. Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. Pharmacogenomics12(6) , 919–923 (2011).
- Opgen-Rhein C , BrandlEJ, MullerDJ et al. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics 11(6) , 773–780 (2010).
- Perez-Iglesias R , MataI, AmadoJA et al. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment. J. Clin. Psychopharmacol. 30(6) , 661–666 (2010).
- Ratzoni G , GothelfD, Brand-GothelfA et al. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J. Am. Acad. Child Adolesc. Psychiatry 41(3) , 337–343 (2002).